Hansen Gwenn bought NRIX
September 1, 2026 · Form 4 insider transaction
Hansen Gwenn bought 1,452 shares of Nurix Therapeutics, Inc. at $1.86 per share, a transaction worth $2.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,452
Price
$1.86
Total value
$2.7K
InsiderHansen Gwenn
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 1, 2026
Filing dateSeptember 1, 2026
Shares owned after118,679
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.